In a week that saw that saw the largest sell-off of the year and had some people thinking a true correction was ready to start, top hedge funds and executives reached into their wallets and made some major purchases. Like the week before, we also saw a huge amount of insider activity concentrated on the buy side, as selling was once again very light in comparison.
Genomic Health (NASDAQ:GHDX) swung to a profit in the fourth quarter on the back of solid revenue growth and expects to have another productive year in 2017 as the company continues to increase reimbursement for its genetic tests.
Related TLT How Bond ETF Flows Affect ETF Sponsors Boring Bonds Boost ETF Asset Growth Related IWM Fast Money Picks For March 10 Fast Money Picks For March 8 Financial Risks: ECB Overstimulation (Seeking Alpha)
Jay Clayton, chairman of the U.S. Securities and Exchange Commission (SEC), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Tuesday, June 27, 2017. Clayton and the Commodity Futures Trading Commission (CFTC) acting chairman defe
Among the initial public offerings I've covered recently, MuleSoft (NYSE:MULE) stood out as one that had no true competitors...at the moment. That's because it has pioneered a new technology layer in enterprise information technology called the application network. An application network is a new
Now that spring has sprung, many homeowners are looking to improve their living space whether its a renovation or redecoration, a gardening or landscaping project, or perhaps its time to become less reliant on the grid.
Finding ways to save energy and money in your home isnt a new concept,